Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer

Fig. 3

A Comparison of recurrence-free survival of patients with initially resectable CRLM stratified by DNA ploidy and tumor burden score (TBS) from the low-risk (diploid DNA ploidy and TBS ≤ 3), moderate-risk (diploid DNA ploidy and TBS > 3 or nondiploid DNA ploidy and TBS ≤ 3) and high-risk (nondiploid DNA ploidy and TBS > 3) groups. B Comparison of overall survival of patients with initially resectable CRLM stratified by DNA ploidy and TBS from the low-risk, moderate-risk and high-risk groups. C Recurrence-free survival related time-dependent areas under curve (AUCs) of the DNA ploidy, TBS and DNA ploidy plus TBS. D Overall survival related time-dependent AUCs of the DNA ploidy, TBS and DNA ploidy plus TBS

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us